Hofseth Biocare ASA: NOTICE OF EXTRAORDINARY GENERAL MEETING
August 09 2022 - 12:30PM
Hofseth Biocare ASA: NOTICE OF EXTRAORDINARY GENERAL MEETING
An Extraordinary General Meeting of Hofseth BioCare ASA will be
held at the company's premises at Kipervikgata 13, 6003 Ålesund, on
30 August 2022 at 13:00 CET.
Please find the notice to the General Meeting attached.
For further information, please contact: Jon Olav Ødegård, CEO
of Hofseth BioCare ASA Phone: +47 93632966 E-mail:
joo@hofsethbiocare.no
About Hofseth BioCare ASA
HBC is a Norwegian consumer and pet health ingredient supplier
and an incubator for new drug leads. Research is ongoing to
identify the individual elements within its ingredients that
modulate inflammation and the immune response with pre-clinical
studies in multiple clinics and university research labs in several
countries. Lead clinical and pre-clinical candidates are focused on
developing an oral pharmaceutical lead program to treat
inflammatory disease driven by eosinophils. Preclinical trial work
with the oil is ongoing to ameliorate lung inflammation in
eosinophilic asthma and COPD ("smokers lung") as well as clinical
work in COVID. Other leads are focused on the protection of the
Gastro-Intestinal (GI) system against inflammation (including
ulcerative colitis and the orphan condition necrotising
enterocolitis) and using peptide fractions of salmon protein
hydrolysate (SPH also known as 'ProGo') as a Medical Food to help
treat age-related Sarcopenia, and as a treatment for Iron
Deficiency Anemia.
The company is founded on the core values of sustainability,
optimal utilization of natural resources and full traceability.
Through an innovative hydrolysis technology, HBC can preserve the
quality of lipids, proteins and calcium from fresh salmon
off-cuts.
Hofseth BioCare's headquarters are in Ålesund, Norway with
branches in Oslo, London, Zürich, New Jersey, and Palo Alto.
This information is subject to the disclosure requirements
pursuant to Section 5-12 of the Norwegian Securities Trading
Act
- NOTICE OF EXTRAORDINARY GENERAL MEETING
Hofseth Biocare Asa (LSE:0Q6H)
Historical Stock Chart
From Jan 2025 to Feb 2025
Hofseth Biocare Asa (LSE:0Q6H)
Historical Stock Chart
From Feb 2024 to Feb 2025